Quinazolinone-dihydropyrano[3,2-b]pyran hybrids as new α-glucosidase inhibitors: Design, synthesis, enzymatic inhibition, docking study and prediction of pharmacokinetic
Maedeh Sherafati(Tehran University of Medical Sciences), Mir Hamed Hajimiri(Biotechnology Research Center), Somayeh Mojtabavi(Tehran University of Medical Sciences), Haleh Hamedifar(Biotechnology Research Center), Mohammad Ali Faramarzi(Tehran University of Medical Sciences), Ebrahim Zabihi(Iran's National Elites Foundation), Maryam Mohammadi‐Khanaposhtani(Babol University of Medical Sciences), Samanesadat Hosseini(Shahid Beheshti University of Medical Sciences), Hossein Rastegar(Iran Nanohealth Committee Food and Drug Organization), Ebrahim Barzegari(Kermanshah University of Medical Sciences), Homa Azizian(Iran University of Medical Sciences), Mohammad Mahdavi(Shaheed Rajaei Cardiovascular Medical and Research Center), Roghieh Mirzazadeh(Pasteur Institute of Iran), Mohammad Asgari(University of Tehran), Bagher Larijani(Tehran University of Medical Sciences)
Cited by 23
Related Papers
The Global Syndemic of Obesity, Undernutrition, and Climate Change: The Lancet Commission report
|The Lancet|2019|3k
Gut microbiota-derived metabolites in obesity: a systematic review
|Bioscience of Microbiota Food and Health|2020|178
The challenge for global health systems in preventing and managing obesity
|Obesity Reviews|2019|128
The assessment of osteoporosis risk factors in Iranian women compared with Indian women
|BMC Musculoskeletal Disorders|2008|126
Machine Learning: A New Prospect in Multi-Omics Data Analysis of Cancer
|Frontiers in Genetics|2022|119